{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:31:51Z","timestamp":1790937111986,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["OFIRG22jul-0081"],"award-info":[{"award-number":["OFIRG22jul-0081"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118464","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T20:37:48Z","timestamp":1755031068000},"page":"118464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The repurposed STAT3 inhibitor pyrimethamine controls mycobacterial infection-induced vascular permeability and mycobacterial burden"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6112-2481","authenticated-orcid":false,"given":"Darryl JY","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8454-7256","authenticated-orcid":false,"given":"Xiangyu","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-1658","authenticated-orcid":false,"given":"Ria","family":"Sorayah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke H.","family":"Hoeppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0260-672X","authenticated-orcid":false,"given":"Stefan H.","family":"Oehlers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2025.118464_bib1","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1073\/pnas.1424563112","article-title":"Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery","volume":"112","author":"Datta","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.biopha.2025.118464_bib2","first-page":"813","article-title":"Infection-induced vascular permeability aids mycobacterial growth","volume":"215","author":"Oehlers","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"7536","key":"10.1016\/j.biopha.2025.118464_bib3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature13967","article-title":"Interception of host angiogenic signalling limits mycobacterial growth","volume":"517","author":"Oehlers","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2025.118464_bib4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.chom.2018.09.004","article-title":"Cyclopropane modification of trehalose dimycolate drives granuloma angiogenesis and mycobacterial growth through vegf signaling","volume":"24","author":"Walton","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1016\/j.biopha.2025.118464_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111817","article-title":"Macrophage NFATC2 mediates angiogenic signaling during mycobacterial infection","volume":"41","author":"Brewer","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118464_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftac009","article-title":"Inhibition of infection-induced vascular permeability modulates host leukocyte recruitment to mycobacterium marinum granulomas in zebrafish","volume":"80","author":"Kam","year":"2022","journal-title":"Pathog. Dis."},{"issue":"14","key":"10.1016\/j.biopha.2025.118464_bib7","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2321336121","article-title":"Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis-infected rabbits","volume":"121","author":"Datta","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118464_bib8","doi-asserted-by":"crossref","first-page":"33162","DOI":"10.1038\/srep33162","article-title":"Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination","volume":"6","author":"Polena","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2025.118464_bib9","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049029","article-title":"Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated vascular permeability","volume":"14","author":"Wang","year":"2021","journal-title":"Dis. Model Mech."},{"issue":"1","key":"10.1016\/j.biopha.2025.118464_bib10","doi-asserted-by":"crossref","first-page":"16610","DOI":"10.1038\/s41598-018-35023-0","article-title":"Host directed therapy for chronic tuberculosis via intrapulmonary delivery of aerosolized peptide inhibitors targeting the IL-10-STAT3 pathway","volume":"8","author":"Upadhyay","year":"2018","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.biopha.2025.118464_bib11","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/cr.2015.123","article-title":"Tuberculosis is associated with expansion of a motile, permissive and immunomodulatory CD16(+) monocyte population via the IL-10\/STAT3 axis","volume":"25","author":"Lastrucci","year":"2015","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118464_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006809","article-title":"STAT3 expression by myeloid cells is detrimental for the T- cell-mediated control of infection with mycobacterium tuberculosis","volume":"14","author":"Gao","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2025.118464_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.626593","article-title":"Clinical profile of Hyper-IgE syndrome in India","volume":"12","author":"Saikia","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118464_bib14","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nprot.2013.068","article-title":"Evaluation of the pathogenesis and treatment of mycobacterium marinum infection in zebrafish","volume":"8","author":"Takaki","year":"2013","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.biopha.2025.118464_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.devcel.2018.06.003","article-title":"A rapid method for directed gene knockout for screening in G0 zebrafish","volume":"46","author":"Wu","year":"2018","journal-title":"Dev. Cell"},{"key":"10.1016\/j.biopha.2025.118464_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-4939-3771-4_14","article-title":"Live imaging of host-pathogen interactions in zebrafish larvae","volume":"1451","author":"Matty","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"14","key":"10.1016\/j.biopha.2025.118464_bib17","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1182\/blood-2015-07-660506","article-title":"Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent","volume":"128","author":"Xiang","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2025.118464_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00262-017-2057-0","article-title":"The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer","volume":"67","author":"Khan","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.biopha.2025.118464_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101531","article-title":"The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase","volume":"298","author":"Heppler","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118464_bib20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000007239","article-title":"Isoniazid plus sulphadoxine-pyrimethamine can reduce morbidity of HIV-positive patients treated for tuberculosis in Africa: a controlled clinical trial","volume":"45","author":"Haller","year":"1999","journal-title":"Chemotherapy"},{"issue":"2","key":"10.1016\/j.biopha.2025.118464_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/clinids\/20.2.244","article-title":"Dapsone\/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus","volume":"20","author":"Opravil","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118464_bib22","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c01594","article-title":"Rational exploration of 2,4-diaminopyrimidines as DHFR inhibitors active against mycobacterium abscessus and mycobacterium avium, two emerging human pathogens","author":"Andrade Meirelles","year":"2024","journal-title":"J. Med Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118464_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.str.2013.09.022","article-title":"Mycobacterium tuberculosis dihydrofolate reductase reveals two conformational states and a possible low affinity mechanism to antifolate drugs","volume":"22","author":"Dias","year":"2014","journal-title":"Structure"},{"issue":"1","key":"10.1016\/j.biopha.2025.118464_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00717-23","article-title":"Pharmacological validation of dihydrofolate reductase as a drug target in mycobacterium abscessus","volume":"68","author":"Aragaw","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2&3","key":"10.1016\/j.biopha.2025.118464_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/ijmr.ijmr_382_23","article-title":"The prevalence of tuberculosis infection in India: a systematic review and meta-analysis","volume":"157","author":"Chauhan","year":"2023","journal-title":"Indian J. Med Res"},{"issue":"5","key":"10.1016\/j.biopha.2025.118464_bib26","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/jac\/dkn330","article-title":"Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs","volume":"62","author":"Sousa","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.biopha.2025.118464_bib27","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1128\/AAC.01658-08","article-title":"Tuberculosis and trimethoprim-sulfamethoxazole","volume":"53","author":"Forgacs","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.biopha.2025.118464_bib28","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/AAC.40.7.1623","article-title":"Plasma pyrimethamine concentrations during long-term treatment for cerebral toxoplasmosis in patients with AIDS","volume":"40","author":"Klinker","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"issue":"19","key":"10.1016\/j.biopha.2025.118464_bib29","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1038\/sj.onc.1208513","article-title":"HIF-1alpha, STAT3, CBP\/p300 and Ref-1\/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas","volume":"24","author":"Gray","year":"2005","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.biopha.2025.118464_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110309","article-title":"Macrophage IL-1beta promotes arteriogenesis by autocrine STAT3- and NF-kappaB-mediated transcription of pro-angiogenic VEGF-A","volume":"38","author":"Mantsounga","year":"2022","journal-title":"Cell Rep."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225006584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225006584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:51:38Z","timestamp":1772797898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225006584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":30,"alternative-id":["S0753332225006584"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118464","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.28.625803","asserted-by":"object"}]},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The repurposed STAT3 inhibitor pyrimethamine controls mycobacterial infection-induced vascular permeability and mycobacterial burden","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118464"}}